Genetic & Molecular Epidemiology Group

Home | Research & Innovation | Scientific Programmes | Human Cancer Genetics Programme | Genetic & Molecular Epidemiology Group

Research Scientists

  • María Evangelina López de Maturana

Post-Doctoral Fellows

  • Brune de Dreuille
  • Pablo Villoslada-Blanco

Graduate Students

  • Mireia Andueza
  • Jiangchuan He
  • Francisco José Jurado
  • Alberto Langtry
  • Nannan Xue


  • María Dolores Alonso
  • Raquel Benítez
  • Lidia Estudillo
  • Lucas Friedman
  • María Olano
  • Laura Paniagua
  • Sergio Sabroso

Visiting Scientist

  • Patricia Aymerich
  • Carlos Castilla

The scope of the research carried out by the Genetic and Molecular Epidemiology Group (GMEG) ranges from the identification of aetiological agents and genetic pathways to the translation of the findings into the clinical and public health domains, focusing on bladder, pancreatic, and breast cancers.

We employ a wide variety of biomarkers, including omics data, to better characterise exposures, genetic susceptibility patterns, and cancer outcomes. While omics data provide a unique opportunity in this regard, their integration with non-omics data poses important challenges, and GMEG explores this methodological field in epidemiologic studies.

The strategic goals of the Group are to:

  • Identify non-genetic and genetic factors, as well as their interactions, associated with cancer development and progression, and with its molecular/omics subphenotypes.
  • Develop and apply statistical/informatics tools to model the risk and course of patients with cancer by integrating epidemiological and clinical data with omics information.
  • Assess clinical and public health strategies for cancer control using newly developed biomarkers and algorithms.